Condition (MeSH)
Cystocele
ClinicalTrials.gov lists 70 trials for Cystocele or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
70 of the 70 trials are tagged with Cystocele itself; the rest are tagged with a narrower condition beneath it.
When did Cystocele trials start? (23)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1/2
- Phase 2
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 6
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 1 |
| 2024 | 2 |
| 2023 | 3 |
| 2022 | 2 |
| 2021 | 3 |
| 2019 | 3 |
| 2018 | 2 |
| 2017 | 3 |
| 2016 | 6 |
Showing 10 of 23 earlier years.
No forecast is made for this condition: it averages 1.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 4 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Cystocele trials in? (6)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1/2 | 1 |
| Phase 2 | 1 |
| Phase 3 | 1 |
| Phase 4 | 7 |
| Not applicable | 38 |
| Observational | 22 |
How many Cystocele trials are recruiting? (7)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 3 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 3 |
| Completed | 45 |
| Terminated | 5 |
Showing 5 of 7 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Cystocele trials? (3)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Coloplast A/S | 2 |
| pfm medical gmbh | 2 |
| ASTORA Women's Health | 1 |
Which drugs are being tested for Cystocele? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Cefuroxime | 1 |
| Poly-L Lactic Acid | 1 |
Interventions as named in the registry (4)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Conjugated Estrogens Cream | 1 |
| Collagen Matrix | 1 |
| Lidocaine Topical | 1 |
| Water-Based Vaginal Lubricant | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Cystocele trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Extrusion | 24 | 1 |
| Bladder injury | 15 | 2 |
| Prolapse | 14 | 1 |
| Incontinence | 6 | 1 |
| Perforation - bladder | 5 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Cystocele? (35)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| A novel suturing technique for natural tissue repair in cystocele treatment. | BMC women's health | 2024 | Yes |
| Comparison of urethral parameters in females presenting cystoceles with and without stress urinary incontinence based on dynamic magnetic resonance imaging: are they different? | Abdominal radiology (New York) | 2024 | Yes |
| Trans-obturator cystocele repair of level 2 paravaginal defect. | International urogynecology journal | 2020 | Yes |
| Safety of Vaginal Mesh Surgery Versus Laparoscopic Mesh Sacropexy for Cystocele Repair: Results of the Prosthetic Pelvic Floor Repair Randomized Controlled Trial. | European urology | 2018 | Yes |
| Cystocele and functional anatomy of the pelvic floor: review and update of the various theories. | International urogynecology journal | 2016 | Yes |
Showing 5 of 35 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.